The FDA has approved the first cell-based gene therapies for sickle cell disease. In this extended episode, Dr. McGinn is joined by Creighton Geneticist and Bioethicist Fr. Kevin FitzGerald and Dr. Ankita Sagar, System Vice President for Clinical Standards and Variation Reduction, to dive into this significant milestone.

Together they discuss CRISPR technology, treatment strategies, bioethics, and what this means for patients and providers alike in our battle against this devastating disease.

Read more: https://www.fda.gov/news-events/press...